GFAP and Alzheimer disease: , 5, 6 neurofilament light (NfL),7, 8 and glial fibrillary acidic protein (GFAP)9, 10 have all been shown to associate with certain AD features, but none can demonstrate the high disease specificity of plasma phosphorylated tau (p‐tau).